| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |